Elevated serum angiopoietin-like protein 6 in women with subsequent pregnancy-induced hypertension: a preliminary study

References

• National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Am J Obstet Gynecol 2000;183:S1–22
   PubMed Web of Science ®Google Scholar
• Redman CW, Sargent IL. Latest advance in understanding preeclampsia. Science 2005;308:1592–4
   PubMed Web of Science ®Google Scholar
• Roberts JM, Gammill HS. Preeclampsia recent insights. Hypertension 2005;46:1243–9
   PubMed Web of Science ®Google Scholar
• Levine RJ, Lam C, Qian C, et al. Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. N Engl J Med 2006;355:992–1005
   PubMed Web of Science ®Google Scholar
• Schobel HP, Fischer T, Heuszer K, et al. Preeclampsia a state of sympathetic overactivity. N Engl J Med 1996;335:1480–5
   PubMed Web of Science ®Google Scholar
• Seely EW, Solomon CG. Insulin resistance and its potential role in pregnancy-induced hypertension. J Clin Endocrinol Metab 2003;88:2393–8
   PubMed Web of Science ®Google Scholar
• Wolf M, Hubel CA, Lam C, et al. Preeclampsia and future cardiovascular disease: potential role of altered angiogenesis and insulin resistance. J Clin Endocrinol Metab 2004;89:6239–43
   PubMed Web of Science ®Google Scholar
• Charnock-Jones DS, Kaufmann P, Mayhew TM. Aspects of human fetoplacental vasculogenesis and angiogenesis. I. Molecular regulation. Placenta 2004;25:103–13
   PubMed Web of Science ®Google Scholar
• Seval Y, Sati L, Celik-Ozenci C, et al. The distribution of angiopoietin-1, angiopoietin-2 and their receptors tie-1 and tie-2 in the very early human placenta. Placenta 2008;29:809–15
   PubMed Web of Science ®Google Scholar
• Nadar SK, Karalis I, Al Yemeni E, et al. Plasma markers of angiogenesis in pregnancy induced hypertension. Thromb Haemost 2004;94:1071–6
   Google Scholar
• Oike Y, Ito Y, Maekawa H, et al. Angiopoietin-related growth factor (AGF) promotes angiogenesis. Blood 2004;103:3760–5
   PubMed Web of Science ®Google Scholar
• Hato T, Tabata M, Oike Y. The role of angiopoietin-like proteins in angiogenesis and metabolism. Trends Cardiovascular Med 2008;18:6–14
   PubMed Web of Science ®Google Scholar
• Oike Y, Akao M, Yasunaga K, et al. Angiopoietin-related growth factor antagonizes obesity and insulin resistance. Nature medicine 2005;11:400–8
   PubMed Web of Science ®Google Scholar
• Ebert T, Bachmann A, Lössner U, et al. Serum levels of angiopoietin-related growth factor in diabetes mellitus and chronic hemodialysis. Metabolism 2009;58:547–51
   PubMed Web of Science ®Google Scholar
• Namkung J, Koh SB, Kong ID, et al. Serum levels of angiopoietin-related growth factor are increased in metabolic syndrome. Metabolism 2011;60:564–8
   PubMed Web of Science ®Google Scholar
• Stepan H, Unversucht A, Wessel N, Faber R. Predictive value of maternal angiogenic factors in second trimester pregnancies with abnormal uterine perfusion. Hypertension 2007;49:818–24
   PubMed Web of Science ®Google Scholar
• Stepan H, Ebert T, Schrey S, et al. Serum levels angiopoietin-related growth factor were increased in preeclampsia. Am J Hypertens 2009;22:314–18
   PubMedGoogle Scholar
• Sibai B, Dekker G, Kupferminc M. Pre-eclampsia. Lancet 2005;365:785–99
   PubMed Web of Science ®Google Scholar
• The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Reports of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 2003;26:S5–20
   PubMed Web of Science ®Google Scholar
• Matsuda M, DeFronzo RA. Insulin sensitivity indices obtained from oral glucose tolerance testing. Comparison with the euglycemic insulin clamp. Diabetes Care 1999;22:1462–70
   PubMed Web of Science ®Google Scholar
• Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412–19
   PubMed Web of Science ®Google Scholar
• Davis ME, Pemberton CJ, Yandle TG, et al. Urocortin-1 infusion in normal humans. J Clin Endocrinol Metab 2004;89:1402–9
   PubMed Web of Science ®Google Scholar
• Eisenhofer G, Goldstein DS, Stull R, et al. Simultaneous liquid-chromatographic determination of 3,4-dihydroxyphenylglycol, catecholamines, and 3,4-dihydroxyphenylalanine in plasma, and their responses to inhibition of monoamine oxidase. Clin Chem 1986;32:2030–3
   PubMed Web of Science ®Google Scholar
• Gidez LI, Miller GJ, Burstein M, et al. Separation and quantitation of subclasses of human plasma high density lipoproteins by a simple precipitation procedure. J Lipid Res 1982;23:1206–23
   PubMed Web of Science ®Google Scholar
• Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972;18:499–502
   PubMed Web of Science ®Google Scholar
• Miida T, Hirayama S. Impacts of angiopoietin-like proteins on lipoprotein metabolism and cardiovascular events. Curr Opin Lipidol 2010;21:70–5
   PubMed Web of Science ®Google Scholar
• Kaaja R, Tikkanen MJ, Viinikka L, Ylikorkala O. Serum lipoproteins, insulin, and urinary prostanoid metabolites in normal and hypertensive pregnant women. Obstet Gynecol 1995;85:353–6
   PubMed Web of Science ®Google Scholar
• Bellamy L, Casas JP, Hingorani AD, Williams DJ. Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systemic review and meta-analysis. Br Med J 2007;335:974–86
   PubMed Web of Science ®Google Scholar
• Kaaja RJ, Pöyhönen-Alho MK. Insulin resistance and sympathetic overactivity in women. J Hypertens 2006;24:131–41
   PubMed Web of Science ®Google Scholar
• Lambert GW, Straznicky NE, Lambert EA, et al. Sympathetic nervous activation in obesity and the metabolic syndrome – causes, consequences and therapeutic implications. Pharmacol Ther 2010;126:159–72
   PubMed Web of Science ®Google Scholar
• Kaaja RJ, Leinonen A, Moore P, et al. Effect of changes in body posture on vasoactive hormones in pre-eclamptic women. J Hum Hypertens 2004;18:789–94
   Google Scholar
• Isgaard J, Granata R. Ghrelin in cardiovascular disease and atherogenesis. Mol Cell Endocrinol 2011;340:59–64
   Google Scholar
• Valsamakis G, Margeli A, Vitoratos N, et al. The role of maternal gut hormones in normal pregnancy: fasting plasma active glucagon-like peptide 1 level is a negative predictor of fetal abdomen circumference and maternal weight change. Eur J Endocrinol 2010;162:897–903
   PubMed Web of Science ®Google Scholar
• Solomon CG, Seely EW. Hypertension in pregnancy. Endocrinol Metab Clin North Am 2006;35:157–71
   PubMed Web of Science ®Google Scholar